Johan Heemskerk


Prof. Johan Heemskerk graduated in Biology and Chemistry at Radboud University Nijmegen. At the same university, he performed doctoral research on the biosynthesis of plant lipids, with post-doctoral projects at the universities of Hamburg, Helsinki and Cambridge (UK). In 1986, he moved to Maastricht University, with positions at the Departments of Human Biology and Biochemistry. He is a recipient of the BACH-ISTH award for contributions to hemostasis. He participates in the following international consortia: European Platelet Network (EUPLAN); BRIDGE-UK, Horizon 2020 TAPAS and TICARDIO, Interreg EMR PolyValve.

Since 2000, he is a Principal Investigator at CARIM, where he studies signal transduction processes and cell-cell communication in blood cells in relation to hemostasis, thrombosis, atherosclerosis, vascular biology and nutrition. Main topics in his programme are the biochemical, cell-biological and physiological regulation of platelet-dependent coagulation and the importance of this process for thrombus formation, stability and embolism. His research encompasses experimental and intervention studies with blood cells from both human and animal sources, with an emphasis on flow-dependent perfusion models using microfluidics. Within consortia, his laboratory establishes platelet proteomes in mice, healthy subjects and defined patients.

Department of Biochemistry
Universiteitssingel 50, 6229 ER Maastricht
PO Box 616, 6200 MD Maastricht
Room: H4.308

  • 2020
    • van Geffen, J. P., Swieringa, F., van Kuijk, K., Tullemans, B. M. E., Solari, F. A., Peng, B., Clemetson, K. J., Farndale, R. W., Dubois, L. J., Sickmann, A., Zahedi, R. P., Ahrends, R., Biessen, E. A. L., Sluimer, J. C., Heemskerk, J. W. M., & Kuijpers, M. J. E. (2020). Mild hyperlipidemia in mice aggravates platelet responsiveness in thrombus formation and exploration of platelet proteome and lipidome. Scientific Reports, 10(1), [21407].
    • Heinzmann, A. C. A., Karel, M. F. A., Coenen, D. M., Vajen, T., Meulendijks, N. M. M., Nagy, M., Suylen, D. P. L., Cosemans, J. M. E. M., Heemskerk, J. W. M., Hackeng, T. M., & Koenen, R. R. (2020). Complementary roles of platelet alpha(IIb)beta(3) integrin, phosphatidylserine exposure and cytoskeletal rearrangement in the release of extracellular vesicles. Atherosclerosis, 310, 17-25.
    • Veninga, A., De Simone, I., Heemskerk, J. W. M., Ten Cate, H., & van der Meijden, P. E. J. (2020). Clonal hematopoietic mutations linked to platelet traits and the risk of thrombosis or bleeding. Haematologica-the Hematology Journal, 105(8), 2020-2031.
    • Brouns, S. L. N., van Geffen, J. P., Campello, E., Swieringa, F., Spiezia, L., van Oerle, R., Provenzale, I., Verdoold, R., Farndale, R. W., Clemetson, K. J., Spronk, H. M. H., van der Meijden, P. E. J., Cavill, R., Kuijpers, M. J. E., Castoldi, E., Simioni, P., & Heemskerk, J. W. M. (2020). Platelet-primed interactions of coagulation and anticoagulation pathways in flow-dependent thrombus formation. Scientific Reports, 10(1), 11910. [11910].
    • Nagy, M., Perrella, G., Dalby, A., Becerra, M. F., Quintanilla, L. G., Pike, J. A., Morgan, N., Gardiner, E. E., Heemskerk, J. W. M., Azocar, L., Miquel, J. F., Mezzano, D., & Watson, S. P. (2020). Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions. Blood advances, 4(13), 2953-2961.
    • Swieringa, F., Solari, F. A., Pagel, O., Beck, F., Huang, J., Feijge, M. A. H., Jurk, K., Koerver-Keularts, I. M. L. W., Mattheij, N. J. A., Faber, J., Pohlenz, J., Russo, A., Stumpel, C. T. R. M., Schrander, D. E., Zieger, B., van Der Meijden, P. E. J., Zahedi, R. P., Sickmann, A., & Heemskerk, J. W. M. (2020). Impaired iloprost-induced platelet inhibition and phosphoproteome changes in patients with confirmed pseudohypoparathyroidism type Ia, linked to genetic mutations in GNAS. Scientific Reports, 10(1), [11389].
    • Thaventhiran, J. E. D., Allen, H. L., Burren, O. S., Rae, W., Greene, D., Staples, E., Zhang, Z., Farmery, J. H. R., Simeoni, I., Rivers, E., Maimaris, J., Penkett, C. J., Stephens, J., Deevi, S. V. V., Sanchis-Juan, A., Gleadall, N. S., Thomas, M. J., Sargur, R. B., Gordins, P., ... Vries, M. (2020). Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature, 583(7814), 90-+.
    • Kroone, C., Vos, M., Rademakers, T., Kuijpers, M., Hoogenboezem, M., van Buul, J., Heemskerk, J. W. M., Ruf, W., van Hylckama Vlieg, A., Versteeg, H. H., Goumans, M-J., de Vries, C. J. M., Kurakula, K., & INVENT Consortium (2020). LIM-only protein FHL2 attenuates vascular tissue factor activity, inhibits thrombus formation in mice and FHL2 genetic variation associates with human venous thrombosis. Haematologica-the Hematology Journal, 105(6), 1677-1685.
    • Shi, C., Kim, T., Steiger, S., Mulay, S. R., Klinkhammer, B. M., Baeuerle, T., Melica, M. E., Romagnani, P., Moeckel, D., Baues, M., Yang, L., Brouns, S. L. N., Heemskerk, J. W. M., Braun, A., Lammers, T., Boor, P., & Anders, H-J. (2020). Crystal Clots as Therapeutic Target in Cholesterol Crystal Embolism. Circulation Research, 126(8), E37-E52.
    • Brouns, S. L. N., Provenzale, I., van Geffen, J. P., van der Meijden, P. E. J., & Heemskerk, J. W. M. (2020). Localized endothelial-based control of platelet aggregation and coagulation under flow: A proof-of-principle vessel-on-a-chip study. Journal of Thrombosis and Haemostasis, 18(4), 931-941.